Cancer Clinical Trials Cooperative Group Activities

National Cancer Institute Cooperative Groups

National Cancer Institute (NCI) cooperative groups consist of networks of researchers who develop and conduct cancer treatment clinical trials throughout the nation. Emphasis is placed on the development and conduct of large, multicenter, randomized phase 3 studies.

The Stanford Cancer Institute (SCI) is active in the following NCI cooperative group: 

Stanford ECOG-ACRIN Affiliates Program Handout

Southwest Oncology Group (SWOG)

National Cancer Institute Clinical Trials Network

The SCI is a recipient of a U10 Lead Academic Participating Site award as part of the National Cancer Institute's Clinical Trials Network (NCTN). Through this network we offer many NCTN trials as potential treatment options for our patients.

Our faculty are involved in:

  • Scientific contributions to the NCTN.
  • Participate as lead investigators on national multi-center cancer clinical trials.

Through our ECOG-ACRIN affiliation SCI has ongoing partnerships with community hospitals throughout the Greater Bay Area. The SCI is committed to providing the broadest access possible to NCTN trials and therapeutic advances they may offer.


For more information on SCI cooperative group activities and/or community hospital partnerships contact:

Miriam Bischoff

MS, MBA Executive Administrative Director, 
Clinical Research Stanford Cancer Institute